• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

总胆固醇变异性对经皮冠状动脉介入治疗后临床结局的影响。

The Effect of Total Cholesterol Variability on Clinical Outcomes After Percutaneous Coronary Intervention.

机构信息

Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

Department of Geriatrics, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

出版信息

Front Public Health. 2022 Feb 8;10:804031. doi: 10.3389/fpubh.2022.804031. eCollection 2022.

DOI:10.3389/fpubh.2022.804031
PMID:35211443
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8860968/
Abstract

AIM

Exploring the risk factors of prognosis in patients undergoing percutaneous coronary intervention (PCI) is of great importance. Our aim of the study is to investigate the association between variability in total cholesterol (TC) level and major adverse cardiovascular and cerebrovascular events (MACCE) in patients after PCI.

METHODS

Between April 2004 and December 2009, 909 patients who underwent primary PCI and with at least three TC values were included in the final study. TC variability was calculated using four indices: standard deviation (SD), coefficient of variation (CV), the average successive variability (ASV), variability independent of the mean (VIM). MACCE comprised all-cause mortality, non-fatal myocardial infarction (MI), unplanned revascularization, hospitalization for heart failure, and non-fatal stroke.

RESULTS

There were 394 cases of MACCE during the follow-up period. When the subjects were divided into quartile groups by CV of TC, high CV groups were associated with a higher hazard ratio of MACCE than for lower CV groups. In multivariable adjusted models, TC variability and MACCE remained correlated [HR (95% CI): Q2, 1.17 (0.86-1.58); Q3, 1.38 (1.03-1.85); Q4, 1.63 (1.22-2.17)]. Similar patterns of MACCE were noted by quartiles of SD, ASV, and VIM.

CONCLUSION

Visit-to-visit TC variability is positively correlated with MACCE in patients after PCI.

摘要

目的

探讨经皮冠状动脉介入治疗(PCI)患者预后的危险因素具有重要意义。本研究旨在探讨 PCI 后患者总胆固醇(TC)水平变化与主要不良心脑血管事件(MACCE)的关系。

方法

本研究纳入 2004 年 4 月至 2009 年 12 月期间行直接 PCI 治疗且至少有 3 次 TC 值的 909 例患者。采用标准差(SD)、变异系数(CV)、平均连续变化率(ASV)和均值独立变异(VIM)4 项指标评估 TC 变异性。MACCE 包括全因死亡率、非致死性心肌梗死(MI)、计划外血运重建、心力衰竭住院和非致死性卒中。

结果

随访期间共发生 394 例 MACCE。根据 TC 的 CV 将患者分为四分位组时,CV 较高的组发生 MACCE 的风险比高于 CV 较低的组。在多变量校正模型中,TC 变异性与 MACCE 仍相关[HR(95%CI):Q2 为 1.17(0.86-1.58);Q3 为 1.38(1.03-1.85);Q4 为 1.63(1.22-2.17)]。SD、ASV 和 VIM 的四分位组也观察到了类似的 MACCE 模式。

结论

PCI 后患者 TC 水平的变异性与 MACCE 呈正相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e3/8860968/f8f31ffeafaf/fpubh-10-804031-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e3/8860968/f8f31ffeafaf/fpubh-10-804031-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e3/8860968/f8f31ffeafaf/fpubh-10-804031-g0001.jpg

相似文献

1
The Effect of Total Cholesterol Variability on Clinical Outcomes After Percutaneous Coronary Intervention.总胆固醇变异性对经皮冠状动脉介入治疗后临床结局的影响。
Front Public Health. 2022 Feb 8;10:804031. doi: 10.3389/fpubh.2022.804031. eCollection 2022.
2
Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention.经皮冠状动脉介入治疗后随访 LDL、HDL 和非 HDL-胆固醇变异性对死亡率和心血管结局的影响。
Atherosclerosis. 2018 Dec;279:1-9. doi: 10.1016/j.atherosclerosis.2018.10.012. Epub 2018 Oct 17.
3
[Impact of short-time anticoagulant therapy after selective percutaneous intervention on prognosis of patients with coronary artery disease].[选择性经皮介入治疗后短期抗凝治疗对冠心病患者预后的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Feb 24;47(2):108-116. doi: 10.3760/cma.j.issn.0253-3758.2019.02.007.
4
Relationship between small dense low density lipoprotein and cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.急性冠状动脉综合征经皮冠状动脉介入治疗患者小而密低密度脂蛋白与心血管事件的关系。
BMC Cardiovasc Disord. 2021 Apr 12;21(1):169. doi: 10.1186/s12872-021-01979-7.
5
Association of variability in uric acid and future clinical outcomes of patient with coronary artery disease undergoing percutaneous coronary intervention.尿酸变异性与经皮冠状动脉介入治疗的冠心病患者未来临床结局的关系。
Atherosclerosis. 2020 Mar;297:40-46. doi: 10.1016/j.atherosclerosis.2020.01.025. Epub 2020 Jan 30.
6
The stress hyperglycemia ratio, an index of relative hyperglycemia, as a predictor of clinical outcomes after percutaneous coronary intervention.应激性高血糖比值作为相对高血糖的一个指标,可作为经皮冠状动脉介入治疗后临床结局的预测因子。
Int J Cardiol. 2017 Aug 15;241:57-63. doi: 10.1016/j.ijcard.2017.02.065. Epub 2017 Feb 22.
7
[Outcome of patients with coronary artery disease and left ventricular ejection fraction less than 50% undergoing percutaneous coronary intervention].冠状动脉疾病且左心室射血分数低于50%的患者接受经皮冠状动脉介入治疗的结果
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Dec 24;45(12):1058-1066. doi: 10.3760/cma.j.issn.0253-3758.2017.12.010.
8
Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).三维分叉角度对左主干冠状动脉疾病经皮冠状动脉介入治疗后 5 年预后的影响:SYNTAX 试验(紫杉醇药物洗脱支架与心脏搭桥术的联合治疗)的一项亚组研究。
JACC Cardiovasc Interv. 2013 Dec;6(12):1250-60. doi: 10.1016/j.jcin.2013.08.009.
9
Relation of Stature to Outcomes in Korean Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction (from the INTERSTELLAR Registry).韩国急性ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗的身高与预后的关系(来自星际注册研究)
Am J Cardiol. 2016 Jul 15;118(2):177-82. doi: 10.1016/j.amjcard.2016.04.046. Epub 2016 May 5.
10
[Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].[经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗无保护左主干冠状动脉分叉病变的长期预后比较]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jan 25;45(1):19-25. doi: 10.3760/cma.j.issn.0253-3758.2017.01.005.

引用本文的文献

1
Total Cholesterol Variability and the Risk of Osteoporotic Fractures: A Nationwide Population-Based Cohort Study.总胆固醇变异性与骨质疏松性骨折风险:一项基于全国人群的队列研究
J Pers Med. 2023 Mar 11;13(3):509. doi: 10.3390/jpm13030509.

本文引用的文献

1
Associations Between C-Reactive Protein, Obesity, Sex, and PCI Outcomes: The Fat of the Matter.C反应蛋白、肥胖、性别与经皮冠状动脉介入治疗结果之间的关联:关键所在
JACC Cardiovasc Interv. 2020 Dec 28;13(24):2893-2895. doi: 10.1016/j.jcin.2020.10.047.
2
Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI.吸烟对 STEMI 患者直接经皮冠状动脉介入治疗结局的影响。
J Am Coll Cardiol. 2020 Apr 21;75(15):1743-1754. doi: 10.1016/j.jacc.2020.02.045.
3
Which is the worst risk factor for the long-term clinical outcome? Comparison of long-term clinical outcomes between antecedent hypertension and diabetes mellitus in South Korean acute myocardial infarction patients after stent implantation.
哪种风险因素对长期临床结局的影响最大?支架植入术后韩国急性心肌梗死患者中既往高血压与糖尿病对长期临床结局的比较。
J Diabetes. 2020 Feb;12(2):119-133. doi: 10.1111/1753-0407.12979. Epub 2019 Sep 9.
4
Intra-individual variability of total cholesterol is associated with cardiovascular disease mortality: A cohort study.个体内总胆固醇变异性与心血管疾病死亡率相关:一项队列研究。
Nutr Metab Cardiovasc Dis. 2019 Nov;29(11):1205-1213. doi: 10.1016/j.numecd.2019.07.007. Epub 2019 Jul 12.
5
Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention.经皮冠状动脉介入治疗后随访 LDL、HDL 和非 HDL-胆固醇变异性对死亡率和心血管结局的影响。
Atherosclerosis. 2018 Dec;279:1-9. doi: 10.1016/j.atherosclerosis.2018.10.012. Epub 2018 Oct 17.
6
Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks.血压变异性与不同基线风险的高血压患者心血管事件和死亡风险。
Eur Heart J. 2018 Jun 21;39(24):2243-2251. doi: 10.1093/eurheartj/ehx760.
7
Visit-to-visit variability of lipid measurements as predictors of cardiovascular events.随访间血脂变异性对心血管事件的预测价值。
J Clin Lipidol. 2018 Mar-Apr;12(2):356-366. doi: 10.1016/j.jacl.2017.12.003. Epub 2017 Dec 20.
8
Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study.胆固醇变异性与死亡率、心肌梗死和卒中等风险的关系:一项全国范围内基于人群的研究。
Eur Heart J. 2017 Dec 21;38(48):3560-3566. doi: 10.1093/eurheartj/ehx585.
9
The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study.辛伐他汀和阿托伐他汀对接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者的肾脏保护作用:一项观察性研究。
Medicine (Baltimore). 2017 Aug;96(32):e7351. doi: 10.1097/MD.0000000000007351.
10
Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study.血糖失调状态下甘油三酯和高密度脂蛋白胆固醇血脂异常与冠心病及缺血性中风风险:强心研究
Diabetes Care. 2017 Apr;40(4):529-537. doi: 10.2337/dc16-1958. Epub 2017 Jan 25.